Cryopreserved arterial allografts for in situ reconstruction of infected arterial vessels

European Journal of Vascular and Endovascular Surgery

Volumn 27, Issue 6, 2004, Pages 597-602

  Teebken, Omke E ^a   Pichlmaier, M A ^a   Brand, S ^a   Haverich, A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Allograft; Aorto enteric fistula; Arterial graft infection; Mycotic aneurysm

Indexed keywords

AMOXICILLIN; CIPROFLOXACIN; CLINDAMYCIN; METRONIDAZOLE; TEICOPLANIN; VANCOMYCIN;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ALLOGRAFT; ANEURYSM RUPTURE; AORTOINTESTINAL FISTULA; ARTERY RECONSTRUCTION; CAUSE OF DEATH; CLINICAL ARTICLE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; FOLLOW UP; GRAFT INFECTION; HUMAN; HYPOVOLEMIC SHOCK; MALE; MULTIPLE ORGAN FAILURE; MYCOTIC ANEURYSM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL TIME;

EID: 2442555992     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejvs.2004.01.027     Document Type: Article

References (19)

1. Gibbons CP, Ferguson CJ, Fligelstone LJ, Edwards K. Experience with femoro-popliteal vein as a conduit for vascular reconstruction in infected fields. Eur J Vasc Endovasc Surg 2003; 25:424-431.
2. Vogt PR, Brunner-La Rocca HP, Lachat M, Ruef C, Turina MI. Technical details with the use of cryopreserved arterial allografts for aortic infection: influence on early and midterm mortality. J Vasc Surg 2002; 35(1):80-86.
3. Verhelst R, Lacroix V, Vraux H, Lavigne JP, Vandamme H, Limet R, Nevelsteen A, Bellen SB, Vasseur MA, Wozniak B, Goffin Y. Use of cryopreserved arterial homografts for management of infected prosthetic grafts: a multicentre study. Ann Vasc Surg 2000; 14:602-607.
4. Bandyk DF, Novotney ML, Jonhson BL, Back MR, Roth SR. Use of rifampicin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections. J Surg Res 2001; 95:44-49.
5. Vogt PR, Turina MI. Cryopreserved aortic homografts for mycotic aneurysms and infected arterial grafts. In: Yankah AC, Yakoub MH, Hetzer R, eds. Cardiac valve allografts. Darmstadt: Steinkopff, 1997: 227-241.
6. Cebotari S, Mertsching H, Kallenbach K, Kostin S, Repin O, Batrinac A, Kleczka C, Ciubotaru A, Haverich A. Construction of autologous human heart valves based on an acellular allograft matrix. Circulation 2002; 106(Suppl 1):I63-I68.
7. Pons VG, Wurtz R. Vascular graft infections: a 25-year experience of 170 cases. J Vasc Surg 1991; 13(5):751-753.
8. Fiorani P, Speziale F, Rizzo L, Fadda GF. In situ replacement of infected aortic graft. In: Greenhalgh RM, ed. Vascular and endovascular surgical techniques, 4 ed. London: WB Saunders, 2001: 165-169.
9. Noel AA, Gloviczki P, Cherry Jr KJ, Safi H, Goldstone J, Morasch MD, Johansen KH. Abdominal aortic reconstruction in infected fields: early results of the United States cryopreserved aortic allograft registry. J Vasc Surg 2002; 35(5):847-852.
10. Beard J, Chong PL. Heterografts and homografts have their place. In: Greenhalgh RM, ed. Vascular and endovascular controversies. London: BIBA Publishing, 2003: 27-35.
11. Bandyk DF, Novotney ML, Back MR, Jonhson BL, Schmacht DC. Expanded application of in situ replacement for prosthetic graft infection. J Vasc Surg 2001; 34:411-420.
12. Nevelsteen A, Feryn T, Lacroix H, Suy R, Goffin Y. Experience with cryopreserved arterial allografts in the treatment of prosthetic graft infections. Cardiovasc Surg 1998; 6(4):378-383.
13. Locati P, Novali C, Socrate AM, Costantine E, Morlacchi E, Piazzalunga G, Constantini S. The use of arterial allografts in aortic graft infections. A three year experience on eighteen patients. J Cardiovasc Surg (Torino) 1998; 39(6):735-741.
14. Chiesa R, Astore D, Frigerio S, Garriboli L, Piccolo G, Castellano R, Scalamogna M, Odero A, Pirrelli S, Biasi G, Mingazzini P, Biglioli P, Polvani G, Guarino A, Agrifoglio G, Tori A, Spina G. Vascular prosthetic graft infection: epidemiology, bacteriology, pathogenesis and treatment. Acta Chir Belg 2002; 102(4):238-247.
15. Kieffer E, Bahnini A, Koskas F, Ruotolo C, LeBlevec D, Plissonnier D. In situ allograft replacement of infected infrarenal aortic prosthetic grafts: results in forty-three patients. J Vasc Surg 1993; 17(2):349-355. discussion 355-356.
16. Camiade C, Goldschmidt P, Koskas F, Ricco JB, Jarraya M, Gerota J, Kieffer E. Optimization of the resistance of arterial allografts to infection: comparative study with synthetic prostheses. Ann Vasc Surg 2001; 15(2):186-196.
17. Yacoub M, Rasmi NR, Sundt TM, Lund O, Boyland E, Radley-Smith R, Khaghani A, Mitchell A. Fourteen-year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg 1995; 110(1):186-193.
18. Teebken OE, Mertsching H, Haverich A. Modification of heart valve allografts and xenografts by means of tissue engineering. Transplant Proc 2002; 34:2333.
19. Szilágyi DE, Rodriguez FJ, Smith RF, Elliot JP. Late fate of arterial allografts. Arch Surg 1970; 101:721.